Speakers

Aparna Dagar is Sr Director of regulatory affairs at Fresenius Kabi USA, LLC., where she provides regulatory oversight and strategic direction for the parenteral nutrition, IV solutions and generic drug businesses in US. In her 18 years in the pharmaceutical industry, she has held positions in R&D and Regulatory Affairs with experience in oral, parenteral and combination product drug development. At Fresenius Kabi, Aparna plays a key role in developing and implementing regulatory, clinical and CMC strategies to facilitate product development and approval in the US. Aparna Dagar graduated from the University of Illinois at Chicago where she received her PhD in Biopharmaceutical Sciences.